Idexx Laboratories (IDXX) EBT Margin (2009 - 2026)

Idexx Laboratories (IDXX) has reported EBT Margin for 18 consecutive years, with 31.16% the latest figure, recorded in Q1 2026.

• In Q1 2026, EBT Margin rose 10.0% year-over-year to 31.16%; the TTM figure through Mar 2026 stood at 30.8% (up 221.0% YoY), while the FY2025 annual figure was 30.77%, up 229.0% from the prior year.
• EBT Margin came in at 31.16% for Q1 2026 at Idexx Laboratories, up from 28.15% in the prior quarter.
• The five-year high for EBT Margin was 32.66% in Q2 2025, with the low at 19.88% in Q2 2022.
• Average EBT Margin over 5 years is 28.61%, with a median of 29.26% recorded in 2023.
• Across the five-year window, EBT Margin slumped 1059 bps in 2022 and soared 1042 bps in 2023, its largest moves.
• Year by year, EBT Margin stood at 25.73% in 2022, then gained by 3 bps to 26.58% in 2023, then grew by 1 bps to 26.87% in 2024, then grew by 5 bps to 28.15% in 2025, then gained by 11 bps to 31.16% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 31.16%, 28.15%, and 31.19% for Q1 2026, Q4 2025, and Q3 2025 respectively.